INQOVI is for the treatment of adults with intermediate and high-risk myelodysplastic syndromes (MDS) including chronic myelomonocytic leukemia (CMML), two blood malignancies
FINTEPLA will be launched through a restricted distribution program, called the FINTEPLA Risk Evaluation and Mitigation Strategy (REMS) Program, and is expected to be available through Zogenix’s specialty pharmacy partner Anovo
In addition to services available at Publix pharmacies, in-hospital locations provides access to medications not typically available in traditional pharmacies
Biologics, as part of a recent reorganization, is now joining McKesson’s Provider Solutions business within the Pharmaceutical Solutions and Services (PSaS) business unit
OptimizeRx’s mission is to make healthcare more accessible to more patients by improving affordability and supporting adherence to prescribed treatment plans
Pharmaceutical manufacturers and payers have developed a number of agreements under which reimbursement is contingent on specific outcomes over the last few years
Many medications for elderly patients need to be used with special caution because of age-related changes
The use of precision medicine and targeted therapies in the treatment of cancer is quickly increasing